| EPIC |
EAH |
| Sector |
Pharma and Biotech |
| ISIN |
GB0032036807 |
| Market Sector |
AIM |
| Market Segment |
ASX1 |
| Main Indices |
FTSE AIM All-Share |
| Country of register |
Great Britain |
| Currency |
British Pound |
| Market Cap |
£66.40m |
| NMS |
1,500 |
| Shares in issue |
67.76m |
| Date Listed |
26-Sep-1995 |
| |
Final |
Final |
| Ex-Div |
23-Sep-21 |
26-Sep-19 |
| Paid |
22-Oct-21 |
16-Oct-19 |
| Amount |
1.00p |
7.04p |
| 16:05 |
5,046 @ 99.00p |
| 16:04 |
3,759 @ 99.49p |
| 15:53 |
57 @ 99.00p |
| 15:53 |
15 @ 99.00p |
| 15:53 |
1 @ 99.00p |
| CFO |
Christopher Wilks |
| CEO |
David Hallas |
Top of Page
You are here:
research